Scholtz & Company’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-16,625
| Closed | -$111K | – | 63 |
|
|
2021
Q3 | $111K | Buy |
+16,625
| New | +$111K | 0.04% | 67 |
|
|
2021
Q1 | – | Sell |
-36,125
| Closed | -$650K | – | 73 |
|
|
2020
Q4 | $650K | Sell |
36,125
-700
| -2% | -$12.6K | 0.25% | 51 |
|
|
2020
Q3 | $523K | Sell |
36,825
-125
| -0.3% | -$1.78K | 0.23% | 51 |
|
|
2020
Q2 | $185K | Buy |
+36,950
| New | +$185K | 0.09% | 58 |
|